Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 20, Issue 10, Pages 1111-1115Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/14712598.2020.1807933
Keywords
Immunotherapy; monoclonal antibodies; severe acute respiratory syndrome coronavirus 2; COVID-19